Currency | ||||||
NEWS | ||||||
UPDATE 1-New shingles vaccine shines as currency hits GSK earnings (Adds details on products, context). By Ben Hirschler. LONDON, April 25 (Reuters) - Drugmaker GlaxoSmithKline reported a 2 percent fall in both sales and earnings in the first quarter on Wednesday as a stronger pound offset a promising start for its new shingles vaccine Shingrix. The product, which is a ...
| ||||||
Currency weighs on GlaxoSmithKline first-quarter sales and earnings LONDON (Reuters) - Drugmaker GlaxoSmithKline (GSK.L) reported a 2 percent fall in both sales and earnings in the first quarter on Wednesday as a stronger pound offset a promising start for its new shingles vaccine Shingrix. FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia ...
| ||||||
Huhtamäki Oyj's Interim Report January 1 - March 31, 2018: Solid comparable growth, negative ... Net sales were EUR 725 million (EUR 739 million); EBIT was EUR 60 million (EUR 63 million); EPS was EUR 0.40 (EUR 0.43); Comparable net sales growth was 5% in total and 8% in emerging markets; Currency movements had a negative impact of EUR 59 million on the Group's net sales and EUR 4 ...
| ||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |